Volume 52, Number 7, 1434-1441, DOI: 10.1007/s00125-009-1378-8

Published in partnership with the

Logo

European Association for the Study of Diabetes

Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus

Y. Kawashima, J. Chen, H. Sun, D. Lann, R. J. Hajjar, S. Yakar and D. LeRoith

View Related Documents

Abstract

Aims/hypothesis  

Although it is known that lipid metabolism plays a role in insulin resistance in type 2 diabetes and in obesity, the mechanism is still largely unknown. Apolipoprotein E (ApoE) regulates plasma lipid levels and also plays a role in the uptake of lipids into various tissues. To investigate whether the suppression of whole-particle lipoprotein uptake into tissues affects insulin responsiveness and the diabetic condition, we examined the effect of an ApoE (also known as Apoe) gene deletion in MKR mice, a mouse model of type 2 diabetes.

Methods  

ApoE −/− , MKR, ApoE −/− /MKR and control mice were placed on a high-fat, high-cholesterol diet for 16 weeks. Glucose tolerance, serum insulin, blood glucose, insulin tolerance, tissue triacylglycerol content and atherosclerotic lesions were assessed.

Results  

ApoE −/− /MKR and ApoE −/− mice showed significantly improved blood glucose, glucose tolerance and insulin sensitivity. Reduced triacylglycerol content in liver and reduced fat accumulation in liver and adipose tissue were found in ApoE −/− /MKR and ApoE −/− mice compared with control and MKR mice. ApoE −/− and ApoE −/− /MKR mice demonstrated similarly large atherosclerotic lesions, whereas MKR and control mice had small atherosclerotic lesions.

Conclusions/interpretation  

We demonstrated that ApoE deficiency abrogates insulin resistance in a mouse model of type 2 diabetes, suggesting that lipid accumulation in tissue is a major cause of insulin resistance in this mouse model.

Keywords  ApoE gene deletion - Atherosclerosis - MKR mouse model of type 2 diabetes

Fulltext Preview

Image of the first page of the fulltext document